BIMI International Medical Statistics
Share Statistics
BIMI International Medical has 13.96M shares outstanding. The number of shares has increased by 20.46% in one year.
Shares Outstanding | 13.96M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 20.46% |
Owned by Institutions (%) | n/a |
Shares Floating | 1.48M |
Failed to Deliver (FTD) Shares | 17 |
FTD / Avg. Volume | 0.73% |
Short Selling Information
The latest short interest is 153.39K, so 1.1% of the outstanding shares have been sold short.
Short Interest | 153.39K |
Short % of Shares Out | 1.1% |
Short % of Float | 10.34% |
Short Ratio (days to cover) | 0.27 |
Valuation Ratios
The PE ratio is -0.15 and the forward PE ratio is null.
PE Ratio | -0.15 |
Forward PE | null |
PS Ratio | 0.28 |
Forward PS | null |
PB Ratio | 0.81 |
P/FCF Ratio | -0.32 |
PEG Ratio | n/a |
Enterprise Valuation
BIMI International Medical Inc. has an Enterprise Value (EV) of 6.40M.
EV / Earnings | -0.29 |
EV / Sales | 0.54 |
EV / EBITDA | -0.36 |
EV / EBIT | -0.42 |
EV / FCF | -0.62 |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.58.
Current Ratio | 0.92 |
Quick Ratio | 0.61 |
Debt / Equity | 0.58 |
Total Debt / Capitalization | 36.71 |
Cash Flow / Debt | -4.37 |
Interest Coverage | -4.47 |
Financial Efficiency
Return on equity (ROE) is -5.52% and return on capital (ROIC) is -143.76%.
Return on Equity (ROE) | -5.52% |
Return on Assets (ROA) | -0.63% |
Return on Capital (ROIC) | -143.76% |
Revenue Per Employee | 39.97K |
Profits Per Employee | -75.52K |
Employee Count | 296 |
Asset Turnover | 0.33 |
Inventory Turnover | 1.29 |
Taxes
Income Tax | 6.09K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.57% in the last 52 weeks. The beta is 1.16, so BIMI International Medical 's price volatility has been higher than the market average.
Beta | 1.16 |
52-Week Price Change | -99.57% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.87 |
Relative Strength Index (RSI) | 40.86 |
Average Volume (20 Days) | 2.32K |
Income Statement
In the last 12 months, BIMI International Medical had revenue of $11.83M and earned -$22.35M in profits. Earnings per share was $-8.4.
Revenue | 11.83M |
Gross Profit | 1.95M |
Operating Income | -15.34M |
Net Income | -22.35M |
EBITDA | -17.97M |
EBIT | -15.34M |
Earnings Per Share (EPS) | -8.4 |
Balance Sheet
The company has $2.34M in cash and $5.46M in debt, giving a net cash position of -$3.12M.
Cash & Cash Equivalents | 2.34M |
Total Debt | 5.46M |
Net Cash | -3.12M |
Retained Earnings | -70.14M |
Total Assets | 35.04M |
Working Capital | 4.21M |
Cash Flow
In the last 12 months, operating cash flow was -$10.26M and capital expenditures $0, giving a free cash flow of -$10.26M.
Operating Cash Flow | -10.26M |
Capital Expenditures | 0 |
Free Cash Flow | -10.26M |
FCF Per Share | -3.85 |
Margins
Gross margin is 16.48%, with operating and profit margins of -129.65% and -188.94%.
Gross Margin | 16.48% |
Operating Margin | -129.65% |
Pretax Margin | -182.77% |
Profit Margin | -188.94% |
EBITDA Margin | -151.88% |
EBIT Margin | -129.65% |
FCF Margin | -86.69% |
Dividends & Yields
BIMI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -84000% |
FCF Yield | -9794.38% |
Analyst Forecast
Currently there are no analyst rating for BIMI.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 12, 2022. It was a backward split with a ratio of 1:10.
Last Split Date | Dec 12, 2022 |
Split Type | backward |
Split Ratio | 1:10 |
Scores
Altman Z-Score | -3.41 |
Piotroski F-Score | 3 |